SK-II
Product brand
UnclaimedJapanese premium skincare brand known for its Pitera-based Facial Treatment Essence.
Last updated August 31, 2026
Overview
SK-II, pronounced S-K-Two, is a Japanese premium skincare brand owned by Procter & Gamble. The brand is associated most strongly with Facial Treatment Essence, a liquid skincare product formulated around Pitera, SK-II's name for a yeast-derived bio-ingredient. Its identity combines Japanese beauty positioning, high-end retail presentation, consultation-led selling, and a focus on skin-conditioning products. The origins of SK-II trace to research conducted in Japan during the 1970s. Scientists investigating naturally derived cosmetic ingredients noticed that older workers at a sake brewery appeared to have unusually smooth and youthful-looking hands despite their age. Their hands were repeatedly exposed to fermented yeast during the brewing process. Subsequent investigation led to the isolation of a yeast-based extract for cosmetic use. SK-II built its product proposition around this extract, which it calls Pitera, and launched as a branded skincare line in the early 1980s. The brand became part of P&G through the company's 1991 acquisition of Max Factor. Under P&G ownership, SK-II retained its Japanese premium identity while receiving broader international distribution and marketing support. Its expansion first moved beyond Japan into other East Asian markets, including China and South Korea. In 2000, the brand entered the United Kingdom, initially using selected high-end retail locations where consultants introduced consumers to the products. It later expanded to the United States and additional markets across Asia, Europe, and Australia. SK-II's best-known offering is Facial Treatment Essence, often treated by consumers and retailers as the brand's signature product. The wider portfolio is focused on facial skincare rather than color cosmetics, with products positioned around skin conditioning, hydration, brightening, texture, and the appearance of signs of aging. The brand's premium pricing and specialist retail presentation distinguish it from mass-market skincare sold through ordinary supermarket and drugstore channels. SK-II has also experienced regulatory and reputational challenges. In China in 2005, a consumer complaint concerning advertising and an alleged allergic reaction led P&G to pay a fine, withdraw certain products, suspend sales, and close SK-II counters while refund arrangements were established. Sales were suspended for approximately two weeks in South Korea during the same period before authorities stated that the products were safe. P&G later announced that Chinese sales would resume in late 2006 after regulators concluded that trace levels of the substances at issue were unlikely to harm human health. The brand is now marketed internationally as a premium Japanese skincare solution. Its principal geographic strength remains East Asia, while its distribution also includes North America, Europe, and Australia. P&G's ownership, the continued prominence of Pitera, and the global recognition of Facial Treatment Essence remain central to SK-II's brand architecture.
History
SK-II's development began in Japan during the 1970s, when scientists were examining naturally derived ingredients for cosmetic applications. A commonly repeated origin story describes their observation that elderly workers at a sake brewery had hands that remained unusually smooth and clear. Although the workers' faces showed signs of age, their hands were repeatedly immersed in fermented yeast during the brewing process. This observation directed research toward compounds associated with yeast fermentation. Researchers eventually isolated a yeast-derived extract suitable for cosmetic use. SK-II refers to this ingredient as Pitera, and it became the technological and marketing foundation of the brand. The line was launched in the early 1980s and is generally dated to 1980 in brand descriptions. From its beginning, SK-II was positioned as a premium Japanese skincare range rather than a mass-market toiletries brand. The product concept emphasized a distinctive active ingredient and a specialized skincare ritual. The most recognizable result of this development was Facial Treatment Essence. The product became the brand's central signature and helped define SK-II's identity in international markets. Rather than competing primarily through a broad assortment of inexpensive products, the brand built recognition around a small number of premium facial-care offerings and the explanation of their ingredients and intended skin benefits. P&G acquired SK-II as part of its 1991 purchase of Max Factor. The acquisition brought the Japanese brand into a large international consumer-products group and created the basis for wider geographic expansion. P&G subsequently extended SK-II beyond Japan into East Asian markets such as China and South Korea. In 2000, the brand entered the United Kingdom. Its early British distribution was concentrated in selected high-end stores, where consultants helped explain the products and introduce shoppers to the brand. The brand later expanded into the United States and other international markets. By 2018, reported markets included Australia, Indonesia, Malaysia, Singapore, Spain, and Thailand, in addition to Japan, China, South Korea, the United Kingdom, and the United States. This distribution pattern reflects SK-II's strongest regional connection to East Asian premium beauty while also showing its presence in Europe, North America, and Australia. The principal interruption to this expansion came in 2005. In China, a consumer alleged that an SK-II product had been inaccurately advertised and had caused an allergic reaction. P&G agreed to a 200,000 yuan fine, withdrew several products, and suspended the brand's Chinese sales. It also closed sales counters and created a hotline for refund applications. The company's proposed return process became part of the controversy because consumers were reportedly asked to sign a product-safety agreement releasing P&G from liability when returning purchases. South Korean sales were also suspended for about two weeks, although authorities later announced that the products were safe. P&G announced a planned return to the Chinese market in late 2006 after regulators concluded that the trace levels of the substances in question were unlikely to be harmful to human health. The episode remains an important part of SK-II's corporate history because it affected distribution, consumer confidence, and regulatory relations in two major Asian markets. SK-II remains an active P&G-owned premium skincare brand. Its historical development is defined by the Japanese fermentation-research origin of Pitera, the prominence of Facial Treatment Essence, P&G's acquisition of the brand through Max Factor, and international expansion through selective premium retail. Its public brand identity continues to center on Japanese skincare expertise and Pitera-based facial-care products.
- 2018
Broad international market presence documented
[1]Reported markets include Australia, Indonesia, Malaysia, Singapore, Spain, and Thailand, alongside the brand's established markets in Japan, East Asia, the United Kingdom, and the United States.
- 2006
Planned return to the Chinese market
[1]P&G announces that SK-II sales in China will resume after regulators determine that the trace levels of the substances under review are unlikely to harm human health.
- 2005
China and South Korea sales disruption
[1]A consumer complaint in China leads to a fine, product withdrawals, and a temporary Chinese sales suspension. South Korean sales are also suspended for approximately two weeks before authorities declare the products safe.
- 2000
United Kingdom expansion
[1]SK-II expands into the United Kingdom, initially focusing on selected high-end stores and consultant-led product introduction.
- 1991
P&G acquires SK-II through Max Factor transaction
[1]SK-II becomes part of Procter & Gamble when P&G acquires Max Factor and its associated brand portfolio.
- 1980
SK-II launches
[1]The SK-II skincare brand is launched in Japan around the beginning of the 1980s, built around the yeast-derived ingredient later branded as Pitera.
- 1970
Yeast research begins in Japan
[1]Japanese scientists investigate naturally derived cosmetic ingredients after observing the unusually smooth hands of older sake-brewery workers who handled fermented yeast.
Products and positioning
Premium Japanese skincare centered on Pitera and consultation-led, high-end beauty retail.
Facial skincare essence
Facial Treatment Essence
SK-II's signature product and the offering most closely associated with the brand. Facial Treatment Essence is a liquid facial-care product built around Pitera, SK-II's name for its yeast-derived cosmetic ingredient. It functions as the central entry point to the brand's skincare regimen and is sold as a premium treatment rather than a conventional mass-market toner.
Ingredient-centered skincare range
Pitera skincare
The broader SK-II range is organized around Pitera, a yeast-derived extract isolated for cosmetic use during research in Japan. Pitera provides the brand with a consistent ingredient story across its facial-skincare portfolio and supports SK-II's positioning around Japanese formulation expertise and skin conditioning.
Facial skincare
SK-II facial skincare range
Beyond Facial Treatment Essence, SK-II sells a premium facial-skincare assortment. The brand is principally associated with treatment-oriented facial products rather than color cosmetics, and its retail model has historically emphasized explanation, consultation, and use as part of a coordinated skincare routine.
Controversies
2005
Chinese advertising and product-safety controversy
A Chinese consumer alleged inaccurate advertising and an allergic reaction connected with an SK-II product. P&G agreed to a 200,000 yuan fine, withdrew several products, suspended Chinese sales, closed sales counters, and arranged a refund hotline. The company later planned a return after Chinese regulators said that the trace levels under review were unlikely to harm human health.
2005
Temporary South Korean sales suspension
SK-II sales in South Korea were suspended for approximately two weeks during the regional product-safety controversy. Sales resumed after authorities announced that the products were safe.
Brand decisions
2005
Temporary withdrawal from ChinaOtherBackground
A consumer complaint concerning advertising and an alleged allergic reaction led to regulatory and reputational pressure in China.
Action taken
P&G withdrew several products, suspended SK-II sales, closed Chinese sales counters, and established a hotline for refund applications.
Aftermath
P&G announced a planned return to the Chinese market in late 2006 after regulators assessed the substances at issue as unlikely to injure human health.
Fine. 200,000 yuan (2005)
2000
Selective premium-retail expansion in the United KingdomStrategyBackground
SK-II began entering markets outside its established East Asian base.
Action taken
The brand launched in selected high-end British stores and used consultants to introduce consumers to its products.
Aftermath
This supported a premium, education-led route to market as SK-II continued expanding internationally.
1991
Integration into P&G through Max Factor acquisitionM&ABackground
P&G acquired Max Factor and thereby obtained ownership of SK-II.
Action taken
The brand was incorporated into P&G's international consumer-products portfolio while retaining its Japanese premium skincare identity.
Aftermath
P&G subsequently expanded SK-II beyond Japan into additional East Asian and Western markets.
Recent events
SK-II continues international expansion as a Procter & Gamble prestige beauty brand[3]
Other
SK-II is marketed internationally through Procter & Gamble’s beauty operations, with particular prominence in Japan and Asian premium skincare markets.
SK-II promotes the Change Destiny platform[3]
Campaign
The brand’s Change Destiny communications platform presents skincare and personal identity through themes of agency, confidence and resistance to externally imposed expectations.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/sk-ii · Editorial policy · How profiles are compiled